Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
abrdn Life Sciences InvestorsHQL -2.47%51 Dividend Payout Ratio is 0.49 as of Mar. 2026, which is 22% below its 10-year median of 0.63. GuruFocus rates HQL with a GF Scoreâ„¢ of 51/100 and a GF Valueâ„¢ of $62.01 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 938 Asset Management companies, abrdn Life Sciences Investors ranks better than 76.23% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. abrdn Life Sciences Investors's Dividend Payout Ratio for the
months ended in Mar. 2026 was 0.49.
The historical rank and industry rank for abrdn Life Sciences Investors's Dividend Payout Ratio or its related term are showing as below:
HQL'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.29 Med: 0.63 Max: 1.62
Current: 0.29
During the past 9 years, the highest Dividend Payout Ratio of abrdn Life Sciences Investors was 1.62. The lowest was 0.29. And the median was 0.63.
HQL's Dividend Payout Ratio is ranked better than 76.23% of 938
companies
in the Asset Management industry
Industry Median: 0.67
vs HQL: 0.29
During the past 9 years, the highest Trailing Annual Dividend Yield of abrdn Life Sciences Investors was 14.51%. The lowest was 6.65%. And the median was 9.55%.
During the past 12 months, abrdn Life Sciences Investors's average Dividends Per Share Growth Rate was -1.50% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 7.40% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 2.60% per year.
During the past 9 years, the highest 3-Year average Dividends Per Share Growth Rate of abrdn Life Sciences Investors was 7.40% per year. The lowest was -4.50% per year. And the median was -0.30% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
abrdn Life Sciences Investors (NYSE:HQL) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
abrdn Life Sciences Investors Dividend Payout Ratio Related Terms
abrdn Life Sciences Investors Dividend Payout Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
abrdn Life Sciences Investors Dividend Payout Ratio Chart
HQL vs IIM, NOAH, FAX: Dividend Payout Ratio Comparison
For the Asset Management subindustry, abrdn Life Sciences Investors's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
abrdn Life Sciences Investors Dividend Payout Ratio vs Asset Management Industry
For the Asset Management industry and Financial Services sector, abrdn Life Sciences Investors's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where abrdn Life Sciences Investors's Dividend Payout Ratio falls into.
abrdn Life Sciences Investors Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
abrdn Life Sciences Investors (HQL) has a Dividend Payout Ratio of 0.49 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on abrdn Life Sciences Investors and its competitors. This is 22% below median its historical median of 0.63. Over the past decade, abrdn Life Sciences Investors' Dividend Payout Ratio has ranged from 0.29 to 1.62. According to the industry distribution chart, abrdn Life Sciences Investors ranks #223 out of 938 companies in the Asset Management industry, placing it in the top 23.8%.
Is abrdn Life Sciences Investors' Dividend Payout Ratio too high?
abrdn Life Sciences Investors' current Dividend Payout Ratio of 0.49 is 22% below median its 10-year median of 0.63. Over the past 10 years, this metric has ranged from a low of 0.29 to a high of 1.62. The Asset Management industry median Dividend Payout Ratio is 0.67. abrdn Life Sciences Investors' value of 0.49 is 26.9% below this industry median. Based on the distribution chart, abrdn Life Sciences Investors ranks #223 out of 938 companies in the Asset Management industry, which is in the top quartile — a strong position relative to peers. Overall, abrdn Life Sciences Investors has a GF Score™ of 51/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does abrdn Life Sciences Investors' Dividend Payout Ratio compare to IIM and NOAH?
According to the Asset Management industry distribution chart, abrdn Life Sciences Investors ranks #223 out of 938 companies for Dividend Payout Ratio. This places abrdn Life Sciences Investors in the top 24% of its industry — outperforming the majority of peers. The industry median Dividend Payout Ratio is 0.67. abrdn Life Sciences Investors' value of 0.49 is 26.9% below this benchmark. Historically, abrdn Life Sciences Investors' own Dividend Payout Ratio has ranged from 0.29 to 1.62 over the past decade. While the company's 10-year median is 0.63 vs. the industry median of 0.67, abrdn Life Sciences Investors has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for an Asset Management company?
The median Dividend Payout Ratio among Asset Management companies is 0.67, based on 938 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. abrdn Life Sciences Investors's current Dividend Payout Ratio of 0.49 is 26.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on abrdn Life Sciences Investors and its competitors. For the Asset Management industry, the median Dividend Payout Ratio is 0.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. abrdn Life Sciences Investors's current Dividend Payout Ratio is 0.49, which is 22% below median its own 10-year median of 0.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is abrdn Life Sciences Investors stock overvalued right now?
Based on GuruFocus' analysis, abrdn Life Sciences Investors (HQL) is currently considered Significantly Undervalued. The stock's GF Value™ is $62.01, compared to a current price of $22.11 — trading 64.3% below its estimated fair value. The current Dividend Payout Ratio is 0.49, which is 22% below median its 10-year median of 0.63 and 26.9% below the Asset Management industry median of 0.67. abrdn Life Sciences Investors' overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For abrdn Life Sciences Investors (HQL), the current Dividend Payout Ratio is 0.49 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is abrdn Life Sciences Investors (HQL) Overvalued in 2026?
Based on GuruFocus' analysis, abrdn Life Sciences Investors stock appears to be undervalued.
The current stock price of $22.11 is trading 64.3% below its estimated GF Value™ of $62.01.
GuruFocus considers abrdn Life Sciences Investors to be Significantly Undervalued.
Key valuation signals for HQL:
Dividend Payout Ratio: 0.49 (22% below median its 10-year median of 0.63)
GF Value™: $62.01 vs. price of $22.11 (64.3% below fair value)
Industry Position: 26.9% below the Asset Management median (#223 of 938)
No single metric tells the full story. See the HQL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.
51GF Score
Get the complete analysis for HQL
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HQL has been successfully added to your 
